Menu
Annual · values2025202420232022
Operating Cash Flow2.20 B USD1.77 B USD3.17 B USD334.00 M USD
Depreciation & Amortization557.00 M USD622.00 M USD627.00 M USD731.00 M USD
Stock-Based Compensation136.00 M USD254.00 M USD188.00 M USD141.00 M USD
Capital Expenditures475.00 M USD434.00 M USD469.00 M USD295.00 M USD
Cash Flow from Investing-436.00 M USD-425.00 M USD-488.00 M USD-171.00 M USD
Cash Flow from Financing-1.84 B USD-1.56 B USD-2.53 B USD0 USD
Dividends Paid1.58 B USD1.55 B USD766.00 M USD0 USD
Stock Buybacks197.00 M USD235.00 M USD7.00 M USD
Free Cash Flow1.72 B USD1.33 B USD2.70 B USD39.00 M USD

Kenvue Inc. is a global consumer health company focused on over-the-counter medicines, personal care, and wellness products for everyday use. Headquartered in Summit, New Jersey, Kenvue develops and markets a broad portfolio of well-known brands across categories such as pain relief, allergy care, cough and cold, digestive health, baby care, skincare, and oral care. Its products include widely recognized names such as Tylenol, Zyrtec, Benadryl, Neutrogena, Aveeno, Listerine, Johnson’s, Band-Aid, and Visine, which are distributed through pharmacies, mass retailers, e-commerce platforms, and healthcare channels worldwide. Kenvue’s business is organized around meeting consumer needs in self-care and daily health routines, offering non-prescription solutions that support hygiene, symptom relief, and skin and hair health. By combining brand recognition, large-scale distribution, and consumer insight-driven product development, Kenvue plays a significant role in the consumer health market, serving households, caregivers, and professionals across multiple regions.